This signaling/metabolization pathway could also be involved in the HCB modulation of the response to PX since these enzymes of the CYP family also play an important role in the metabolism of PX and it is known that an increase in their expression or activity reduces the PX half-life, thus decreasing chemotherapy efficacy in cancer patients [65]. The gene discussed is PPIG; the disease is cancer.